FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx today announced the acquisition of BioSeek, a drug discovery services company based in South San Francisco, California. BioSeek’s phenotypic screening technology improves the success rate of pharmaceutical research and development by integrating primary cell profiling into the drug discovery process. The proprietary BioMAP® systems incorporate primary human cell-based disease models that generate predictive biological activity profiles for potential drugs. As a result, the technology drives the selection and development of new drug candidates and safer chemicals.
